Applications are now open for Glaucoma Australia’s Quinlivan Research Grants Program.
Supported by The William A Quinlivan Research Fund, Glaucoma Australia will commit AU$200,000 in the second round of its program, and anticipates that individual grants of $50,000 – $100,000 per annum will be awarded for projects up to three years in duration. Seed fund grants could be used to apply for further funding with NHMRC or other agencies.
Since its inception, Glaucoma Australia has committed $1,024,783 to support Australian glaucoma researchers across a diverse range of projects
The William A Quinlivan Research Fund was established in 2006 and now has over $1.8M in assets. Since its inception, Glaucoma Australia has committed $1,024,783 to support Australian glaucoma researchers across a diverse range of projects.
Most recently the Glaucoma Australia Quinlivan Research Grants have funded Dr George Kong, Royal Victorian Eye and Ear Hospital and Professor Jamie Craig, Flinders University. Dr Kong’s translational research project is the world’s first clinical trial to examine the validity of home monitoring using the world’s first software app for tablet devices for glaucoma patients. Professor Jamie Craig’s work aims to improve prediction of glaucoma for every Australian who will develop the disease, with a view to achieving a paradigm shift in the way glaucoma is prevented.
How to Apply
Applications are open from 15 June until 5pm (AEST) 10 August 2020. For details regarding the application process please visit glaucoma.org.au/about-us/research-grants-program.
Submissions will be reviewed by the Research Committee consisting of internationally recognised experts in glaucoma research including the fields of Ophthalmology, Optometry and Pharmacy.
The successful recipients will be announced on World Sight Day, 8 October 2020.
For further information phone (AUS) 1800 500 880 or research@glaucoma.org.au
